Colorectal cancer is the third most common cancer worldwide, accounting for roughly 10% of all cancer diagnoses. In the United States, it is the second leading cause of cancer death, with an estimated 55,230 deaths expected in 2026 alone. Globally, about 1.9 million new cases were diagnosed in 2022, alongside more than 900,000 deaths.
Incidence by the Numbers
Colorectal cancer affects men at notably higher rates than women. The age-adjusted incidence rate for colon cancer is about 35.7 per 100,000 in men compared to 29 per 100,000 in women. For rectal cancer specifically, the gap is even wider: 16.2 per 100,000 in men versus 10.1 in women. This pattern holds across nearly every racial and ethnic group in the U.S.
The reasons for the gender difference aren’t fully understood, but hormonal factors, differences in body fat distribution, and variations in screening behavior all likely play a role. Regardless of sex, colorectal cancer remains one of the cancers you are most likely to encounter over a lifetime.
A Sharp Rise in Younger Adults
One of the most striking trends in cancer statistics is the increase in colorectal cancer among people under 50. Nearly 10% of new colorectal cancer cases worldwide now occur in this age group, a proportion that would have seemed improbable a generation ago. Projections published in the Journal of Clinical Oncology estimate that by 2030, the fastest-growing rates will be in the 40 to 44 age group (rising at about 3.3% per year) and the 35 to 39 age group (rising at about 2.9% per year). The increase is expected across adults aged 25 to 54.
At the same time, rates in older adults are actually declining. People aged 75 to 79 are projected to see their incidence drop significantly by 2030. This divergence is largely attributed to decades of widespread screening in older populations, which catches and removes precancerous growths before they become dangerous. Younger adults, who until recently were not recommended for routine screening, have not benefited from the same protection.
In response, major medical organizations lowered the recommended age for first colonoscopy from 50 to 45. If you’re in that age window and haven’t been screened, this shift was made specifically with the rising trend in mind.
How Screening Changes the Odds
Colonoscopy does more than detect cancer. It prevents it. During the procedure, doctors remove polyps, the small growths that can eventually turn malignant. Past research has linked colonoscopy with as much as a 69% reduction in new colorectal cancer cases and an 88% reduction in the risk of dying from it.
Those numbers come from observational studies, which tend to overestimate benefits because people who get screened are often healthier in other ways. A large randomized trial of more than 84,500 people offered a more conservative picture. When researchers looked at everyone invited to be screened (whether or not they actually went), the reduction in later colorectal cancers was 18%. But among people who actually completed the colonoscopy, the cancer rate dropped by 31% and deaths from colorectal cancer fell by 50%. The takeaway: colonoscopy clearly works, and the benefit scales with whether you actually follow through.
Stool-based tests offer another option. They’re less invasive and can be done at home, though a positive result still requires a follow-up colonoscopy. The important thing is that some form of screening, starting at 45 for average-risk people, catches the disease when it’s most treatable.
Survival Depends Heavily on Stage
The five-year survival rate for colorectal cancer varies enormously depending on how far the disease has spread at diagnosis. Based on CDC data from cancers diagnosed between 2015 and 2021:
- Localized (cancer confined to the colon or rectum): 89.3% five-year survival
- Regional (spread to nearby lymph nodes or tissues): 73.4%
- Distant (spread to other organs like the liver or lungs): 16.4%
That gap between 89% and 16% is one of the starkest in all of oncology. It underscores why early detection matters so much. Localized cancers are often caught during routine screening, before symptoms ever appear. Distant cancers are more likely to be diagnosed after someone notices persistent symptoms like unexplained weight loss, blood in the stool, or a change in bowel habits that lasts weeks.
Risk Factors That Raise Your Chances
Some risk factors for colorectal cancer are within your control, while others are not. A family history of colorectal cancer or polyps increases your risk substantially, especially if a first-degree relative (parent, sibling, or child) was diagnosed before age 50. Inherited genetic syndromes like Lynch syndrome account for a small but significant share of cases.
Modifiable risk factors include a diet high in processed and red meat, obesity, physical inactivity, heavy alcohol use, and smoking. Chronic inflammatory bowel conditions like ulcerative colitis and Crohn’s disease also raise long-term risk, particularly when they’ve been present for many years. Type 2 diabetes is independently associated with higher colorectal cancer rates as well.
No single factor explains the rise in younger adults. Researchers are investigating whether shifts in diet, antibiotic use, the gut microbiome, and rising obesity rates in childhood and adolescence are contributing. For now, the practical implication is straightforward: don’t assume you’re too young to be at risk, and pay attention to persistent digestive symptoms even in your 30s and 40s.